Edgewise Therapeutics, Inc. (EWTX)
EWTX Stock Price Chart
Explore Edgewise Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze EWTX price movements and trends.
EWTX Company Profile
Discover essential business fundamentals and corporate details for Edgewise Therapeutics, Inc. (EWTX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
26 Mar 2021
Employees
117.00
Website
https://www.edgewisetx.comCEO
Kevin Koch
Description
Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing small-molecule treatments for a range of musculoskeletal disorders. Its leading investigational drug, EDG-5506, is an orally administered compound specifically engineered to tackle the fundamental genetic causes of dystrophinopathies, including Duchenne and Becker muscular dystrophy. This candidate has successfully concluded its Phase 1 clinical trial. Beyond EDG-5506, Edgewise maintains a pipeline of precision medicine candidates designed to modulate key muscle proteins, thereby addressing various genetically defined muscle conditions. Established in 2017, the company is headquartered in Boulder, Colorado.
EWTX Financial Timeline
Browse a chronological timeline of Edgewise Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is -$0.48.
Earnings released on 7 May 2026
EPS came in at -$0.46 surpassing the estimated -$0.50 by +8.00%.
Earnings released on 26 Feb 2026
EPS came in at -$0.47 falling short of the estimated -$0.43 by -9.30%.
Earnings released on 6 Nov 2025
EPS came in at -$0.39 surpassing the estimated -$0.40 by +2.50%.
Earnings released on 7 Aug 2025
EPS came in at -$0.34 surpassing the estimated -$0.42 by +19.05%.
Earnings released on 8 May 2025
EPS came in at -$0.43 surpassing the estimated -$0.45 by +4.44%.
Earnings released on 3 Mar 2025
EPS came in at -$0.42 falling short of the estimated -$0.39 by -7.69%.
Earnings released on 7 Nov 2024
EPS came in at -$0.36 surpassing the estimated -$0.37 by +2.70%.
Earnings released on 8 Aug 2024
EPS came in at -$0.34 surpassing the estimated -$0.36 by +5.56%.
Earnings released on 9 May 2024
EPS came in at -$0.33 surpassing the estimated -$0.39 by +15.38%.
Earnings released on 22 Feb 2024
EPS came in at -$0.47 falling short of the estimated -$0.44 by -6.82%, while revenue for the quarter reached $2.25m .
Earnings released on 9 Nov 2023
EPS came in at -$0.41 falling short of the estimated -$0.40 by -2.50%.
Earnings released on 10 Aug 2023
EPS came in at -$0.34 surpassing the estimated -$0.41 by +17.07%.
Earnings released on 11 May 2023
EPS came in at -$0.36 surpassing the estimated -$0.37 by +2.70%.
Earnings released on 23 Feb 2023
EPS came in at -$0.31 surpassing the estimated -$0.36 by +13.89%.
Earnings released on 3 Nov 2022
EPS came in at -$0.34 surpassing the estimated -$0.36 by +5.56%.
Earnings released on 4 Aug 2022
EPS came in at -$0.32 surpassing the estimated -$0.34 by +5.88%.
Earnings released on 11 May 2022
EPS came in at -$0.30 falling short of the estimated -$0.29 by -3.45%.
Earnings released on 24 Feb 2022
EPS came in at -$0.26 surpassing the estimated -$0.28 by +7.14%.
Earnings released on 10 Nov 2021
EPS came in at -$0.26 falling short of the estimated -$0.22 by -18.18%.
Earnings released on 9 Aug 2021
EPS came in at -$0.21 falling short of the estimated -$0.18 by -16.67%.
EWTX Stock Performance
Access detailed EWTX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
